Industry & Policy News

[Alberta Cancer Foundation] The Alberta Cancer Foundation revealed the inaugural recipients of its Game Changer Fund. This transformative initiative aims to accelerate local cancer research by fostering collaboration between researchers and frontline clinicians.

[University of Sheffield] The University of Sheffield and Yorkshire Cancer Research have announced seven world-leading research studies that will aim to help more people survive cancer by exploring new solutions in cancer prevention, diagnosis and treatment.

[Theriva^™ Biologics] Theriva™ Biologics announced that the Independent Data Monitoring Committee recommended the continuation of enrollment as planned into VIRAGE, a multinational, Phase IIb, randomized, open-label, controlled clinical trial evaluating VCN-01 in combination with standard-of-care chemotherapy as a first-line therapy for patients with metastatic PDAC.

[CBC] Experts are watching closely as cases of invasive pneumococcal disease rise in Alberta. The potentially life-threatening illness is caused by bacteria known as Streptococcus pneumoniae, which often strike after viral illnesses.

[Nanyang Technological University] A group of researchers, led by Assoc Prof Ng Yin Kwee from NTU’s School of Mechanical and Aerospace Engineering, has developed a computer program to identify potential tumors in the human breast, making use of the observation that malignant breast tumors distribute heat differently to healthy breast tissue.

[Harvard University] Third-year students at the Harvard John A. Paulson School of Engineering and Applied Sciences worked with the Harvard Stem Cell Institute iPS Core Facility last fall to design a pair of solutions to reduce the time spent on day-to-day operations. They created an automated task management and scheduling system called “WorkFlow,” and a semi-robotic cell imaging system called “CytoScope.”